Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Philippe Wolgen1
Date of Patent
April 11, 2023
1Patent Application Number
157146271
Date Filed
September 25, 2017
1Patent Primary Examiner
The present invention relates to a therapy for vitiligo. In particular the present invention provides a pharmaceutical composition comprising an alpha melanocyte stimulating hormone (alpha-MSH) analogue either alone, in combination with narrow band UVB and/or in combination with one or more corticosteroids, immunosuppressants, anti-inflammatory agents and/or photochemotherapeutic agents for the treatment or prevention of vitiligo.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.